Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selectio...
Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
The currently available immunotherapies already changed the strategy how many cancers are treated from first to last line. Understanding even the most complex heterogeneity in tumor tissue and mapping the spatial cartography of the tumor immunity allows the best and optimized selection of immune modulating agents to (re‐)activate the...
Alternative Titles
Full title
Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5253100d3dc5418d9468002c6e950c84
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5253100d3dc5418d9468002c6e950c84
Other Identifiers
ISSN
2573-8348
E-ISSN
2573-8348
DOI
10.1002/cnr2.1796
